Skip to main content
Agency for Care Effectiveness
  1. Home
  2. Healthcare professionals
  3. ACE Technology Guidances
  4. Drug Guidance
  5. Cetuximab and panitumumab for treating RAS wild-type colorectal cancer
Drug guidance

Cetuximab and panitumumab for treating RAS wild-type colorectal cancer

Cancer

Gastrointestinal tract

1 April 2022

Guidance Recommendations

Subsidy status

Back to top